Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$376,604
New position
Shares Held
1,040
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,387
of 3,140 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261900 WEALTH MANAGEMENT LLC holds $9,846,369 across 9 Drug Manufacturers - General names. AMGN ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,155 | $2,584,771 | |
| 2 | JNJ |
Johnson & Johnson
|
8,399 | $2,133,094 | |
| 3 | ABBV |
AbbVie Inc.
|
6,582 | $1,656,294 | |
| 4 | NVS |
Novartis AG
|
6,153 | $964,298 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,764 | $869,174 | |
| 6 | PFE |
Pfizer Inc
|
23,827 | $573,754 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,040 | $376,604 | |
| 8 | NVO |
Novo Nordisk A S
|
7,465 | $357,872 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $376,604 | 1,040 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||